New vaccine trial aims to train body to fight breast cancer
Disease control
Recruiting now
This is an early-stage study testing a new vaccine designed to teach the body's immune system to recognize and attack HER2-positive breast cancer cells. It is for people with high-risk, locally advanced breast cancer who have already completed standard HER2-targeted therapy. The …
Phase: PHASE1 • Sponsor: Pravin T.P Kaumaya • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC